$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
阿斯利康降糖药达格列净的价格贵吗
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净的使用说明
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净的降糖效果如何
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净的效果如何
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净的最新价格
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净的治疗效果
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净的作用
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净多少钱
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净贵不贵?多少钱
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净国内有吗
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净好用吗
2025-10-19 11:44:20
Check Details
阿斯利康降糖药达格列净可以治疗哪些疾病
2025-10-19 11:44:20
Check Details
1
2
...
5446
5447
5448
5449
5450
5451
5452
...
10218
10219
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
2
Pegloticase (Krystexxa) Complete Medication Guide
3
Vemurafenib (Zelboraf) Complete Medication Guide
4
Guide to Long-Term Ramipril Use: Safety and Renal Function Management
5
Mechanism and Clinical Positioning of Leflunomide: A Comprehensive Guide to csDMARDs
6
Comprehensive Clinical Guide to Risankizumab (Skyrizi): Dosing, Contraindications, and Safety
7
Management Strategies and Long-Term Outcomes Following 6 Months of Pegloticase (Krystexxa) Therapy
8
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
9
Omaveloxolone (Skyclarys): Side Effect Management and Clinical Guide for Friedreich’s Ataxia
10
Linezolid for MRSA Pneumonia: Efficacy Evidence, Clinical Advantages, and Rational Use
11
Navigating Drug Interactions with Daprodustat: Risks, Adjustments, and Safety Protocols
12
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice